WIRE — TAIPEI, July 3, 2026 /PRNewswire/ -- Jyong Biotech Ltd. (Nasdaq: MENS) (the Company or Jyong Biotech), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics, today announced its participation in the BIO International Convention (BIO... The post Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention appeared first on Kosmo Digital.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.